Wnt signaling pathway, a potential target for Alzheimer's disease treatment, is activated by a novel multitarget compound ASS234.
Departamento de Toxicología y Farmacología, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain.
Javier
J
del Pino
Eva
E
Ramos
Oscar M Bautista
OM
Aguilera
José
J
Marco-Contelles
Alejandro
A
Romero
D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects*; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D009447:Neuroblastoma / Q000473:pathology; D047493:PPAR alpha / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology*; D060449:Wnt Signaling Pathway / Q000187:drug effects*
D004791:Enzyme Inhibitors; D007211:Indoles; C570530:N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine; D047493:PPAR alpha; D010880:Piperidines